Shukra [SHUKRAPHAR] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Shukra

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra wins in 11 metrics, Suven Life Sciences wins in 7 metrics, with 0 ties. Shukra appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShukraSuven Life SciencesBetter
P/E Ratio (TTM)275.85-28.01Suven Life Sciences
Price-to-Book Ratio25.6140.49Shukra
Debt-to-Equity Ratio6.650.00Suven Life Sciences
PEG Ratio3.37-0.34Suven Life Sciences
EV/EBITDA100.35-23.32Suven Life Sciences
Profit Margin (TTM)25.68%84.44%Suven Life Sciences
Operating Margin (TTM)25.25%-2,791.92%Shukra
EBITDA Margin (TTM)25.25%N/AN/A
Return on Equity15.24%-146.15%Shukra
Return on Assets (TTM)11.04%-118.91%Shukra
Free Cash Flow (TTM)$51.75M$-1.91BShukra
Dividend Yield3.20%N/AN/A
1-Year Return364.29%46.77%Shukra
Price-to-Sales Ratio (TTM)39.85641.26Shukra
Enterprise Value$18.02B$43.40BSuven Life Sciences
EV/Revenue Ratio45.74577.38Shukra
Gross Profit Margin (TTM)85.71%100.00%Suven Life Sciences
Revenue per Share (TTM)$1$0Shukra
Earnings per Share (Diluted)$0.13$-8.15Shukra
Beta (Stock Volatility)0.320.86Shukra
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shukra vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Shukra
Suven Life Sciences
Shukra Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra-1.99%-0.09%23.88%107.66%67.40%140.74%
Suven Life Sciences0.80%-0.17%-3.10%-15.83%58.82%63.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra364.29%579.49%2,326.06%2,066.67%828.57%828.57%
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%

News Based Sentiment: Shukra vs Suven Life Sciences

Shukra

News based Sentiment: MIXED

September presented a mixed bag for Shukra Pharmaceuticals. While the company achieved a new 52-week high and secured a significant distribution partnership with Wockhardt, it also reported a substantial revenue contraction in FY25. The upcoming warrant issue adds another layer of complexity, making it a pivotal month for the company's future direction.

View Shukra News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Shukra vs Suven Life Sciences

MetricSHUKRAPHARSUVEN
Market Information
Market Cap i₹16.02B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i110,113185,019
90 Day Avg. Volume i340,504147,095
Last Close₹34.45₹208.70
52 Week Range₹5.75 - ₹35.86₹102.50 - ₹299.99
% from 52W High-3.93%-30.43%
All-Time High₹35.86 (Sep 30, 2025)₹338.50 (Apr 13, 2015)
% from All-Time High-3.93%-38.35%
Growth Metrics
Quarterly Revenue Growth0.67%0.86%
Quarterly Earnings Growth1.12%0.86%
Financial Health
Profit Margin (TTM) i0.26%0.84%
Operating Margin (TTM) i0.25%-27.92%
Return on Equity (TTM) i0.15%-1.46%
Debt to Equity (MRQ) i6.650.00
Cash & Liquidity
Book Value per Share (MRQ)₹1.40₹5.04
Cash per Share (MRQ)₹0.24₹2.75
Operating Cash Flow (TTM) i₹66.80M₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹95.75M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i3.20%N/A
Last 12-Month Dividend i₹1.02₹0.00

Valuation & Enterprise Metrics Analysis: Shukra vs Suven Life Sciences

MetricSHUKRAPHARSUVEN
Price Ratios
P/E Ratio (TTM) i275.85-28.01
Forward P/E iN/A10.55
PEG Ratio i3.37-0.34
Price to Sales (TTM) i39.85641.26
Price to Book (MRQ) i25.6140.49
Market Capitalization
Market Capitalization i₹16.02B₹48.20B
Enterprise Value i₹18.02B₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i45.74577.38
Enterprise to EBITDA i100.35-23.32
Risk & Other Metrics
Beta i0.320.86
Book Value per Share (MRQ) i₹1.40₹5.04

Financial Statements Comparison: Shukra vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHUKRAPHARSUVEN
Revenue/Sales i₹53.91M₹18.67M
Cost of Goods Sold i₹7.70M₹0
Gross Profit i₹46.21M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹5.32M₹-521.17M
EBITDA i₹24.28M₹-501.49M
Pre-Tax Income i₹13.73M₹-515.17M
Income Tax i₹3.44M₹0
Net Income (Profit) i₹10.30M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHUKRAPHARSUVEN
Cash & Equivalents i₹121.18M₹150.26M
Total Current Assets i₹654.27M₹754.72M
Total Current Liabilities i₹172.84M₹234.86M
Long-Term Debt i₹31.13MN/A
Total Shareholders Equity i₹628.36M₹1.10B
Retained Earnings i₹143.00M₹-6.01B
Property, Plant & Equipment i₹193.97M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHUKRAPHARSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i110,113185,019
Average Daily Volume (90 Day) i340,504147,095
Shares Outstanding i437.88M218.07M
Float Shares i54.95M67.61M
% Held by Insiders i0.89%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Shukra vs Suven Life Sciences

MetricSHUKRAPHARSUVEN
Last 12-Month Dividend i₹1.02₹0.00
Last 12-Month Dividend Yield i3.20%N/A
3-Year Avg Annual Dividend i₹0.35₹0.00
3-Year Avg Dividend Yield i3.91%N/A
3-Year Total Dividends i₹1.05₹0.00
Ex-Dividend DateSep 23, 2025N/A